|
Mon, 10/22/2018 - 08:58 |
Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX Tests in Guiding Treatment for Breast and Prostate Cancer Patients |
Exact Sciences |
|
Mon, 09/10/2018 - 18:58 |
GSK data presented at ERS further supports its industry-leading respiratory medicines portfolio |
GlaxoSmithKline |
|
Thu, 07/19/2018 - 04:43 |
App, brief intervention may be lifesaver for suicidal teens |
UTSouthwestern |
|
Fri, 06/15/2018 - 10:22 |
JAK Inhibitors Associated with Aggressive Lymphoma |
American Societ... |
|
Thu, 05/31/2018 - 09:41 |
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDAs work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities |
FDA |
|
Wed, 05/30/2018 - 10:47 |
FDA approves new treatment for moderately to severely active ulcerative colitis |
FDA |
|
Tue, 05/29/2018 - 06:24 |
GSK submits regulatory application in Japan for once-daily single inhaler triple therapy FF/UMEC/VI for patients with COPD |
GlaxoSmithKline |
|
Mon, 05/21/2018 - 10:11 |
GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma |
GlaxoSmithKline |
|
Wed, 05/16/2018 - 03:04 |
GSKs industry-leading respiratory research and scientific innovation showcased at ATS conference |
GlaxoSmithKline |
|
Tue, 04/24/2018 - 10:16 |
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD |
GlaxoSmithKline |
|
Wed, 04/18/2018 - 15:59 |
Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD |
GlaxoSmithKline |
|
Tue, 04/17/2018 - 21:37 |
AstraZeneca and Daiichi Sankyo Launch Proton Pump Inhibitor Nexium 10 mg and 20 mg Granules for Suspension, Sachet, in Japan |
Daiichi Sankyo |
|
Wed, 04/04/2018 - 15:27 |
Practicing Tai Chi helps improve respiratory function in patients with COPD |
American Colleg... |
|
Thu, 03/08/2018 - 02:42 |
GSK announces positive EU approval for labelling update to Relvar Ellipta in patients with asthma |
GlaxoSmithKline |
|
Fri, 02/23/2018 - 10:18 |
Confronting the opioid crisis: Q&A with Dr. Natalie Tate |
BlueCross BlueS... |
|
Fri, 01/26/2018 - 02:03 |
GSK announces CHMP positive opinion for labelling update to Relvar Ellipta in patients with asthma |
GlaxoSmithKline |
|
Thu, 12/21/2017 - 05:49 |
What Is Healing Touch? |
Roswell Park Ca... |
|
Thu, 11/23/2017 - 03:50 |
GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy Ellipta |
GlaxoSmithKline |
|
Wed, 09/20/2017 - 02:23 |
GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations |
GlaxoSmithKline |
|
Mon, 09/18/2017 - 17:39 |
Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US |
GlaxoSmithKline |
|
Sun, 09/10/2017 - 23:35 |
Positive results from pioneering Salford Lung Study in asthma published in The Lancet, and presented at European Respiratory Congress |
GlaxoSmithKline |
|
Wed, 08/23/2017 - 09:15 |
ACOG Expands Recommendations to Treat Postpartum Hemorrhage |
ACOG |
|
Mon, 07/24/2017 - 05:25 |
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma |
GlaxoSmithKline |
|
Fri, 07/21/2017 - 05:29 |
GSK submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination |
GlaxoSmithKline |
|
Wed, 06/28/2017 - 08:51 |
Yoga more risky for causing musculoskeletal pain than you might think |
SydneyUniv |
